Arcutis Biotherapeutics Inc (ARQT) USD0.0001
0.23%- This stock can be held in a
Stocks and Shares ISASell:$13.27
Buy:$13.28
Change:
$0.45
(3.30%)
$0.45
(3.30%)Market closed | Prices delayed by at least 15 minutes
Sell:$13.27
Buy:$13.28
Change:$0.45
(3.30%)
$0.45
(3.30%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 2 January 2025 | Howard G WelgusDirector | Sell Regular sell transaction (market) | 10,000 | $14.67 | $146,714.00 | 151,944 |
| 31 December 2024 | Patrick BurnettOther Level A | Sell Tax related | 1,691 | $14.00 | $23,674.00 | 126,978 |
| 20 December 2024 | Todd Franklin WatanabePresident/CEO | Sell Regular sell transaction (market) | 15,000 | $15.17 | $227,566.50 | 823,430 |
| 2 December 2024 | Howard G WelgusDirector | Sell Regular sell transaction (market) | 10,000 | $12.51 | $125,133.00 | 161,944 |
| 30 November 2024 | Todd Franklin WatanabePresident/CEO | Buy Regular purchase transaction | 2,038 | $7.11 | $14,482.03 | 838,430 |
| 30 November 2024 | Masaru (Mas) MatsudaCompany Secretary | Buy Regular purchase transaction | 1,657 | $7.11 | $11,774.64 | 187,030 |
| 30 November 2024 | Larry Todd EdwardsChief Level Officer | Buy Regular purchase transaction | 1,093 | $7.11 | $7,766.86 | 137,728 |
| 22 November 2024 | Patrick BurnettOther Level A | Sell Option/Award related | 16,023 | $10.14 | $162,514.88 | 128,669 |
| 19 November 2024 | Masaru (Mas) MatsudaCompany Secretary | Sell Tax related | 1,775 | $9.68 | $17,190.34 | 181,373 |
| 15 November 2024 | Patrick BurnettOther Level A | Sell Option/Award related | 100 | $10.03 | $1,003.00 | 128,669 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 14 November 2024 | Patrick BurnettOther Level A | Sell Regular sell transaction (market) | 50,749 | $10.29 | $522,435.58 | 128,669 |
| 29 May 2024 | Patrick BurnettOther Level A | Sell Regular sell transaction (market) | 49,952 | $8.72 | $435,386.63 | 209,793 |
| 20 December 2024 | Todd Franklin WatanabePresident/CEO | Sell Regular sell transaction (market) | 15,000 | $15.17 | $227,566.50 | 823,430 |
| 30 May 2024 | Patrick BurnettOther Level A | Sell Option/Award related | 23,000 | $8.75 | $201,319.00 | 209,793 |
| 4 March 2024 | FRAZIER LIFE SCIENCES VIII LPVenture Capital | Buy Regular purchase transaction | 21,052 | $9.50 | $199,994.00 | 8,785,284 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.